Targeted modulation of nitric oxide pathways: Effects on reactive oxygen species, endothelial function, and disease progression in cardiovascular patients

Nitric oxide (NO) is a highly reactive molecule with broad implications in biological, environmental, and industrial contexts. As a free radical, NO plays a vital role in cellular signalling pathways, particularly in regulating vascular tone through vasodilation and in modulating immune responses. However, its reactivity also positions NO as a potential toxicant, contributing to oxidative stress when produced in excess and damaging DNA, proteins, and lipids. This dual nature of NO highlights the importance of its regulation within biological systems, where it can act as both a signalling molecule and a harmful agent under pathological conditions.
In industrial applications, NO is widely used to produce nitric acid, a key component in fertilisers, explosives, and other chemicals. It also has applications in metal refining and semiconductor manufacturing, making it an important compound in modern industry. However, NO emissions from industrial processes and vehicle exhausts contribute significantly to atmospheric pollution. NO interacts with oxygen and volatile organic compounds (VOCs), leading to the formation of nitrogen oxides (NOx), which play a major role in the development of smog, acid rain, and particulate matter. These environmental impacts necessitate the implementation of mitigation strategies, including catalytic converters, selective catalytic reduction (SCR) technologies, and green chemistry innovations, to reduce NO emissions and minimise its detrimental effects on air quality and ecosystems.
Emerging research in NO chemistry is focused on uncovering new therapeutic approaches, particularly in the development of NO-releasing compounds for the treatment of cardiovascular diseases, cancer, and neurodegenerative disorders. Advances in nanotechnology have led to the exploration of NO-releasing nanoparticles for targeted drug delivery, offering more precise therapeutic applications with potentially fewer side effects. Despite these advancements, challenges remain in controlling NO levels in therapeutic contexts, as its short half-life and high reactivity make precise dosing difficult. Moreover, understanding NO’s interactions with other molecules in both physiological and pathological conditions is crucial for improving its application in medical treatments.
Future research must address the gaps in knowledge regarding NO’s role in neurodegenerative diseases, as well as its broader environmental impact, particularly in the context of climate change. The ongoing study of NO’s interactions, its role in human health, and its environmental significance will contribute to the development of more effective therapies and industrial processes while mitigating the negative impacts of NO on ecosystems.